These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33017074)

  • 1. Less severe clinical symptoms of Norwalk virus 8fIIb inoculum compared to its precursor 8fIIa from human challenge studies.
    Liu P; Rahman M; Leon J; Moe C
    J Med Virol; 2021 Jun; 93(6):3557-3563. PubMed ID: 33017074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production and Clinical Evaluation of Norwalk GI.1 Virus Lot 001-09NV in Norovirus Vaccine Development.
    Mateo R; Lindesmith LC; Garg SJ; Gottlieb K; Lin K; Said S; Leon JS; Sims AC; Weber DJ; Baric RS; Tucker SN; Taylor DN
    J Infect Dis; 2020 Mar; 221(6):919-926. PubMed ID: 31628848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease course and viral shedding in experimental Norwalk virus and Snow Mountain virus infection.
    Kirby AE; Shi J; Montes J; Lichtenstein M; Moe CL
    J Med Virol; 2014 Dec; 86(12):2055-64. PubMed ID: 24531909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norwalk virus shedding after experimental human infection.
    Atmar RL; Opekun AR; Gilger MA; Estes MK; Crawford SE; Neill FH; Graham DY
    Emerg Infect Dis; 2008 Oct; 14(10):1553-7. PubMed ID: 18826818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of Norwalk virus inocula: Comparison of endpoint titration and real-time reverse transcription-PCR methods.
    Liu P; Hsiao HM; Jaykus LA; Moe C
    J Med Virol; 2010 Sep; 82(9):1612-6. PubMed ID: 20648618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the 50% human infectious dose for Norwalk virus.
    Atmar RL; Opekun AR; Gilger MA; Estes MK; Crawford SE; Neill FH; Ramani S; Hill H; Ferreira J; Graham DY
    J Infect Dis; 2014 Apr; 209(7):1016-22. PubMed ID: 24253285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral shedding and fecal IgA response after Norwalk virus infection.
    Okhuysen PC; Jiang X; Ye L; Johnson PC; Estes MK
    J Infect Dis; 1995 Mar; 171(3):566-9. PubMed ID: 7876602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norwalk virus: how infectious is it?
    Teunis PF; Moe CL; Liu P; Miller SE; Lindesmith L; Baric RS; Le Pendu J; Calderon RL
    J Med Virol; 2008 Aug; 80(8):1468-76. PubMed ID: 18551613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological correlate of protection against norovirus-induced gastroenteritis.
    Reeck A; Kavanagh O; Estes MK; Opekun AR; Gilger MA; Graham DY; Atmar RL
    J Infect Dis; 2010 Oct; 202(8):1212-8. PubMed ID: 20815703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterotypic humoral and cellular immune responses following Norwalk virus infection.
    Lindesmith LC; Donaldson E; Leon J; Moe CL; Frelinger JA; Johnston RE; Weber DJ; Baric RS
    J Virol; 2010 Feb; 84(4):1800-15. PubMed ID: 20007270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity.
    Czakó R; Atmar RL; Opekun AR; Gilger MA; Graham DY; Estes MK
    Clin Vaccine Immunol; 2015 Feb; 22(2):221-8. PubMed ID: 25540269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence similarity of human caliciviruses and small round structured viruses.
    Cubitt WD; Jiang XJ; Wang J; Estes MK
    J Med Virol; 1994 Jul; 43(3):252-8. PubMed ID: 7931187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal and Cellular Immune Responses to Norwalk Virus.
    Ramani S; Neill FH; Opekun AR; Gilger MA; Graham DY; Estes MK; Atmar RL
    J Infect Dis; 2015 Aug; 212(3):397-405. PubMed ID: 25635121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two human challenge studies confirm high infectivity of Norwalk virus.
    Kirby AE; Teunis PF; Moe CL
    J Infect Dis; 2015 Jan; 211(1):166-7. PubMed ID: 25121553
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of nine sets of PCR primers in the RNA dependent RNA polymerase region for detection and differentiation of members of the family Caliciviridae, Norwalk virus and Sapporo virus.
    Honma S; Nakata S; Kinoshita-Numata K; Kogawa K; Chiba S
    Microbiol Immunol; 2000; 44(5):411-9. PubMed ID: 10888362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human calicivirus infections in Kenya as determined by enzyme immunoassays for three genogroups of the virus.
    Nakata S; Honma S; Numata K; Kogawa K; Ukae S; Adachi N; Jiang X; Estes MK; Gatheru Z; Tukei PM; Chiba S
    J Clin Microbiol; 1998 Nov; 36(11):3160-3. PubMed ID: 9774557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccine development for Norwalk virus].
    Nakata S
    Nihon Rinsho; 2002 Jun; 60(6):1222-7. PubMed ID: 12078098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level excretion of Norwalk-like virus following resolution of clinical illness.
    Marshall JA; Salamone S; Yuen L; Catton MG; Wright JP
    Pathology; 2001 Feb; 33(1):50-2. PubMed ID: 11280609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues.
    El-Kamary SS; Pasetti MF; Mendelman PM; Frey SE; Bernstein DI; Treanor JJ; Ferreira J; Chen WH; Sublett R; Richardson C; Bargatze RF; Sztein MB; Tacket CO
    J Infect Dis; 2010 Dec; 202(11):1649-58. PubMed ID: 20979455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults.
    Johnson PC; Mathewson JJ; DuPont HL; Greenberg HB
    J Infect Dis; 1990 Jan; 161(1):18-21. PubMed ID: 2153184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.